Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14

Results For "Support"

3528 News Found

Teen neuroscience researcher turns ADHD struggles into startup innovation
Medical Device | May 28, 2026

Teen neuroscience researcher turns ADHD struggles into startup innovation

Adya Anubhuti launches ADHD Copilot, an AI-powered platform designed to reduce stress and mental overload


Asahi Kasei bags breakthrough ADC tech in push for safer & more precise cancer therapies
Technology | May 28, 2026

Asahi Kasei bags breakthrough ADC tech in push for safer & more precise cancer therapies

The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs


Hikal swings back to profit in Q4 FY26 despite regulatory hit & strategic charges
News | May 28, 2026

Hikal swings back to profit in Q4 FY26 despite regulatory hit & strategic charges

Hikal’s Q4 profit remained sharply lower year-on-year, falling 71% from Rs. 50.2 crore in Q4 FY25 as the company absorbed regulatory pressures and strategic accounting adjustments


Kyoto–Tokyo consortium launches first-of-its-kind zirconia recycling project for dental waste
News | May 28, 2026

Kyoto–Tokyo consortium launches first-of-its-kind zirconia recycling project for dental waste

Under the new initiative, each company takes on a defined role across the recycling chain


Gandhar Oil posts robust FY26 profit
News | May 28, 2026

Gandhar Oil posts robust FY26 profit

PAT soars 201%, EBITDA up 88% on strong PHPO demand & margin expansion


Morepen Labs posts strong Q4 FY26 net profit
News | May 28, 2026

Morepen Labs posts strong Q4 FY26 net profit

For the full year, standalone gross revenue crossed Rs. 1,700 crore


Quotient Sciences advances AI-designed drug product into Phase I clinical study
News | May 28, 2026

Quotient Sciences advances AI-designed drug product into Phase I clinical study

Company launches clinical study of AI-designed oral formulation following MHRA approval, marking a major milestone in AI-driven drug development.


Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control
Clinical Trials | May 27, 2026

Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control

These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC


Ashish Mukkirwar appointed CFO of Jubilant Pharmova
People | May 27, 2026

Ashish Mukkirwar appointed CFO of Jubilant Pharmova

The finance leader and investment banking veteran to steer global financial strategy, investor relations, and growth initiatives


Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz
News | May 27, 2026

Jubilant Ingrevia delivers 14-quarter high revenue in Q4 FY26 as margins strengthen across biz

The company highlighted continued demand strength and pricing resilience despite global disruptions